Nzhde Agazaryan, PhD, DABR, FAAPM

Chief of Clinical Medical Physics and Dosimetry
Nzhde Agazaryan, PhD, DABR, FAAPM

Professor of Radiation Oncology
Professor of Physics and Biology in Medicine
Chief of Clinical Medical Physics and Dosimetry

Dr. Agazaryan is a Professor of Radiation Oncology, Professor of the Physics and Biology in Medicine, and the Chief of Clinical Medical Physics at the UCLA School of Medicine. His appointment in the Department of Radiation Oncology involves research, teaching and clinical practice. Dr. Agazaryan is a Quality Officer of the UCLA Health’s Faculty Practice Group (FPG) and the UCLA Department of Radiation Oncology. Dr. Agazaryan has been elected a Fellow of the American Association of Physicists (FAAPM). The FAAPM election honors members who have distinguished themselves by their contributions in research, education and leadership.

Dr. Agazaryan is currently the lead professor of the UCLA Physics of Radiation Therapy Graduate Course (PB MED 203) and the Applications of Medical Physics to Clinical Problems: Radiation Therapy Clinical Rotation (PB MED 202C). Dr. Agazaryan is also engaged in mentoring medical physics graduate students, residents and junior faculty. Dr. Agazaryan’s research and clinical interests include stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), with an emphasis on clinical implementation of translational research, clinical trials, small field dosimetry and image-guided radiotherapy (IGRT). He is an investigator of five clinical trials involving the use of Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiotherapy (SBRT). Dr. Agazaryan has made numerous international and national presentations, published over 40 peer-reviewed papers, over 120 abstracts, book editorial, booklet and several book chapters. Dr. Agazaryan is a Diplomate of The American Board of Radiology (DABR) – board certified in Therapeutic Radiologic Physics. He is also California State licensed to conduct therapy machine calibrations and radiation protection surveys.